These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 25329449

  • 1. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia.
    Diro E, Lynen L, Gebregziabiher B, Assefa A, Lakew W, Belew Z, Hailu A, Boelaert M, van Griensven J.
    Trop Med Int Health; 2015 Jan; 20(1):8-16. PubMed ID: 25329449
    [Abstract] [Full Text] [Related]

  • 2. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R.
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [Abstract] [Full Text] [Related]

  • 3. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
    Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, den Boer M, Davidson RN.
    Clin Infect Dis; 2006 Aug 01; 43(3):357-64. PubMed ID: 16804852
    [Abstract] [Full Text] [Related]

  • 4. Treatment outcomes of visceral leishmaniasis in Ethiopia from 2001 to 2017: a systematic review and meta-analysis.
    Gebreyohannes EA, Bhagvathula AS, Abegaz TM, Seid MA.
    Infect Dis Poverty; 2018 Oct 19; 7(1):108. PubMed ID: 30340519
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of malnutrition and associated risk factors among adult visceral leishmaniasis patients in Northwest Ethiopia: a cross sectional study.
    Mengesha B, Endris M, Takele Y, Mekonnen K, Tadesse T, Feleke A, Diro E.
    BMC Res Notes; 2014 Feb 04; 7():75. PubMed ID: 24490749
    [Abstract] [Full Text] [Related]

  • 6. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
    Diro E, Lynen L, Mohammed R, Boelaert M, Hailu A, van Griensven J.
    PLoS Negl Trop Dis; 2014 May 04; 8(5):e2875. PubMed ID: 24854196
    [Abstract] [Full Text] [Related]

  • 7. Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
    Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, Balasegaram M, Hailu A.
    Trans R Soc Trop Med Hyg; 2010 Nov 04; 104(11):706-12. PubMed ID: 20870258
    [Abstract] [Full Text] [Related]

  • 8. Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
    Mengstie TA, Endale HT, Mulaw T, Abdella AM, Mohammed R, Malik T, Dessie G.
    PLoS One; 2021 Nov 04; 16(10):e0257229. PubMed ID: 34597312
    [Abstract] [Full Text] [Related]

  • 9. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
    Aderie EM, Diro E, Zachariah R, da Fonseca MS, Abongomera C, Dolamo BL, Ritmeijer K.
    Trans R Soc Trop Med Hyg; 2017 Mar 01; 111(3):107-116. PubMed ID: 28633331
    [Abstract] [Full Text] [Related]

  • 10. Challenges in the management of visceral leishmaniasis.
    Sundar S, Kumar A.
    Indian Pediatr; 2005 Jun 01; 42(6):523-6. PubMed ID: 15995268
    [No Abstract] [Full Text] [Related]

  • 11. Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
    Kimutai R, Musa AM, Njoroge S, Omollo R, Alves F, Hailu A, Khalil EA, Diro E, Soipei P, Musa B, Salman K, Ritmeijer K, Chappuis F, Rashid J, Mohammed R, Jameneh A, Makonnen E, Olobo J, Okello L, Sagaki P, Strub N, Ellis S, Alvar J, Balasegaram M, Alirol E, Wasunna M.
    Clin Drug Investig; 2017 Mar 01; 37(3):259-272. PubMed ID: 28066878
    [Abstract] [Full Text] [Related]

  • 12. Leishmaniasis: an update of current pharmacotherapy.
    Sundar S, Chakravarty J.
    Expert Opin Pharmacother; 2013 Jan 01; 14(1):53-63. PubMed ID: 23256501
    [Abstract] [Full Text] [Related]

  • 13. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
    Thakur CP, Narayan S, Ranjan A.
    Indian J Med Res; 2004 Sep 01; 120(3):166-72. PubMed ID: 15489554
    [Abstract] [Full Text] [Related]

  • 14. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK.
    N Engl J Med; 2007 Jun 21; 356(25):2571-81. PubMed ID: 17582067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
    Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, Davidson RN.
    Clin Infect Dis; 2011 Dec 21; 53(12):e152-8. PubMed ID: 22016502
    [Abstract] [Full Text] [Related]

  • 17. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C, Diro E, de Lima Pereira A, Buyze J, Stille K, Ahmed F, van Griensven J, Ritmeijer K.
    PLoS Negl Trop Dis; 2018 May 21; 12(5):e0006527. PubMed ID: 29799869
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.
    Tamiru A, Mohammed R, Atnafu S, Medhin G, Hailu A.
    PLoS Negl Trop Dis; 2021 Aug 21; 15(8):e0009713. PubMed ID: 34464401
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.
    Tamiru A, Tigabu B, Yifru S, Diro E, Hailu A.
    BMC Infect Dis; 2016 Oct 10; 16(1):548. PubMed ID: 27724891
    [Abstract] [Full Text] [Related]

  • 20. Malnutrition and intestinal parasitic infections in school children of Gondar, North West Ethiopia.
    Worku N, Erko B, Torben W, Belay M, Kasssu A, Fetene T, Huruy K.
    Ethiop Med J; 2009 Jan 10; 47(1):9-16. PubMed ID: 19743775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.